Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding ModeJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-09-113PRE
Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target口服可生物利用的PI3Kδ 抑制剂的优化和Vps34作为关键选择性靶标的鉴定JOURNAL OF MEDICINAL CHEMISTRYIF6.82019-12-1919PREAI
Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase δ through a Deconstruction and Regrowth ApproachJOURNAL OF MEDICINAL CHEMISTRYIF6.82018-12-1110PREAI
Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA2 InhibitorACS MEDICINAL CHEMISTRY LETTERSIF42016-11-28197OAAI
Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory DiseaseJOURNAL OF MEDICINAL CHEMISTRYIF6.82015-09-03127PREAI
Discovery of 6-Aryl-7-alkoxyisoquinoline Inhibitors of IκB Kinase-β (IKK-β)JOURNAL OF MEDICINAL CHEMISTRYIF6.82009-04-0635PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向